Mohamed Fareh
Senior Research Fellow - Research Focussed
Centre for Cancer Research
31 Scholarly works
14 Projects
HIGHLIGHTS
2026
Journal article
De novo design of potent CRISPR–Cas13 inhibitors
DOI: 10.1038/s41589-025-02136-32026
Journal article
CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics
DOI: 10.1038/s41571-026-01179-22025
Journal article
Systematic evaluation of CrRNA design parameters for optimized Cas13d-mediated RNA targeting in chicken cells
DOI: 10.1007/s10142-025-01776-x2025
Journal article
Efficient mRNA delivery to resting T cells to reverse HIV latency
DOI: 10.1038/s41467-025-60001-22022
Research grants (other domestic)
Sequence-Specific Silencing of Oncogenic Drivers With Personalized Cas13 RNA Therapeutics
2022
Research grants (other domestic)
mRNA-based Antiviral Therapeutics for SARS-CoV-2 Using Cas13
2022
Research grants (ARC, NHMRC, MRFF)
mRNA-based Antiviral Therapeutics for SARS-CoV-2 Using Cas13
RECENT SCHOLARLY WORKS
2024
Journal article
Principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision
DOI: 10.1126/sciadv.adl07312024
Journal article
Single-base tiled screen unveils design principles of PspCas13b for potent and off-target-free RNA silencing
DOI: 10.1038/s41594-024-01336-02024
Journal article
CRISPR-Cas13b-mediated suppression of HBV replication and protein expression
DOI: 10.1016/j.jhep.2024.05.0252024
Conference Proceedings
CRISPR-Cas13b-mediated suppression of hepatitis B surface antigen-pre-clinical investigations of a new therapeutic approach
DOI: 10.1016/s0168-8278(24)02081-62024
Journal article
Utilizing CRISPR-Cas13 as a novel functional genomics tool to characterize PAX3-FOXO1 in alveolar rhabdomyosarcoma
DOI: 10.1158/1538-7445.AM2024-10942022
Conference Proceedings
De novo design of CRISPR-Cas13b enables efficient silencing of SARS-CoV-2 variants and tumour pathogenic RNAs with near single-base precision
DOI: 10.1016/j.pathol.2021.12.057
RECENT PROJECTS
2025
Research grants (international)
Direct and Indirect Targeting of HIV Tat for Selective RNA Degradation and Protein Suppression
2025
Research grants (other domestic)
Developing CRISPR Cas13 Antiviral Therapeutics for Respiratory Pathogens of Pandemic Potential